← Back to Patent Explorer
US4895809A Expired / Lapsed US ⏱️ 0.0 years remaining

Immobilized antigen-antibody displacement process

Assignee: Varian Inc
•
Filing: 1984-01-09
•
Granted: 1990-01-23
•
Expires: 2004-01-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and apparatus for quantitatively analyzing, in a flowing stream, materials in a biological or chemical sample utilizes immobilized antobodies reversibly precharged with fluorescently labeled antigens. The labeled antigens are competitively displaced by unlabeled antigens in the sample, after the sample antigens have been segregated into zones by a chromatographic device, such as the reverse phase high performance liquid chromatograph. Displaced labeled antigens are measured by a fluorescence detector. A plurality of antibody species may be concurrently utilized, thereby allowing quantification of a plurality of antigens from a single sample.

Inventors

  • 👤 Timothy D. Schlabach
  • 👤 Fred E. Regnier

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 01:23
CPC Classifications
G; G01; G01N; G01N30/00; G01N30/02; G01N30/84; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/5302; G01N33/536; G01N33/537; G01N33/538; G01N33/543; G01N33/54366; G01N21/00; G01N21/62; G01N21/63; G01N21/64; G01N21/6428; G01N2021/6439; G01N30/62; G01N30/74; G01N2030/746; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10S436/807; Y10S436/808; Y10S436/824; Y10T; Y10T436/00; Y10T436/25; Y10T436/25375; Y10T436/255

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 150 words
A method for quantitatively determining the amount of a plurality of antigens in a biological sample, comprising the steps of: (a) segregating the sample antigens into a plurality of distinct zones by high performance or other liquid chromatographic techniques; and (b) allowing said segregated antigen zones to pass through a post-segregation detection system including a competitive binding component and a detector, said competitive binding component including (i) immobilized antibodies of a plurality of distinct species effective to specifically and reversibly couple to particular sample antigens, and (ii) fluorescently labeled antigens corresponding to the sample antigens that have specifically and reversibly coupled to the corresponding immobilized antibodies, such that as said antigen zones pass through said detection system, said labeled antigens are competitively displaced by corresponding sample antigens and enter said detector (c) detecting the amount of displaced fluorescence-labeled antigen, said detected amount corresponding quantitatively to a given sample antigen zone.
Claim 2
Independent Claim 150 words
A method for quantitatively determining the amount of a plurality of antigens in a biological sample, comprising the steps of: (a) segregating the sample antigens into a plurality of distinct zones by high performance or other liquid chromatographic techniques; and (b) allowing said segregated antigen zones to pass through a post-segregation detection system including a competitive binding component and a detector, said competitive binding component including (i) immobilized antibodies of a plurality of distinct species effective to specifically and reversibly couple to particular sample antigens, and (ii) fluorescently labeled antigens corresponding to the sample antigens that have specifically and reversibly coupled to the corresponding immobilized antibodies, such that as said antigen zones pass through said detection system, said labeled antigens are competitively displaced by corresponding sample antigens and enter said detector (c) detecting the amount of displaced fluorescence-labeled antigen, said detected amount corresponding quantitatively to a given sample antigen zone.
Claim 3
Dependent Claim 50 words
The method of claim 1 wherein the segregation step is performed by a liquid chromatographic device wherein the sample antigens are introduced into a column in which a carrier fluid is used to differentially move said sample antigens along a tube packed with material having varying affinity with said antigens.
Claim 4
Dependent Claim 46 words
The method of claim 2 wherein said chromatographic technique is a high performance liquid chromatography, and (said column is coupled to said competitive binding component) to allow a continuous flow of eluent including said antigen zones to pass through said column into said competitive binding component.
Claim 5
Dependent Claim 36 words
The method of claim 3 wherein said immobilized antibodies represent a plurality of immunological specificities, and are preselected to correspond to a plurality of known antigens of the sample to be applied to said liquid chromatograph.
Claim 6
Dependent Claim 17 words
The method of claim 4 wherein said antigens are segregated by reverse phase, high performance liquid chromatography.
Claim 7
Dependent Claim 17 words
The method of claim 1, wherein the segregation step is performed by steric exclusion or ion-exchange chromatography.
Claim 8
Dependent Claim 38 words
The method of claim 6, wherein said segregation step is coupled to said competitive binding component to allow a continuous flow of eluent including said antigen zones to pass through said segregation step into said competitive binding component.
Claim 9
Dependent Claim 36 words
The method of claim 7, wherein said immobilized antibodies represent a plurality of immunological specificities, and are preselected to correspond to a plurality of known antigens of the sample to be applied to said liquid chromatograph.
Claim 10
Independent Claim 152 words
A device for quantitatively determining the amount of a plurality of antigens in a biological sample, comprising: (a) a high performance liquid chromatographic column; (b) a competitive binding component including (i) immobilized antibodies of a plurality of distinct species effective to specifically and reversibly couple to the sample antigens, and (ii) fluorescently labeled antigens corresponding to the sample antigens that are specifically and reversibly coupled to corresponding said immobilized antibodies, said column and said competitive binding component coupled to allow a continuous flow of eluent to pass from said column into said binding component; and (c) a detector effective to quantitatively determine the amount of fluorescently labeled antigen displaced from said competitive binding component by the passage of unlabeled sample antigen through said binding component, said detector being coupled to said competitive binding component to allow a continuous flow of said eluent to pass from said competitive binding component to said detector.
Claim 11
Independent Claim 152 words
A device for quantitatively determining the amount of a plurality of antigens in a biological sample, comprising: (a) a high performance liquid chromatographic column; (b) a competitive binding component including (i) immobilized antibodies of a plurality of distinct species effective to specifically and reversibly couple to the sample antigens, and (ii) fluorescently labeled antigens corresponding to the sample antigens that are specifically and reversibly coupled to corresponding said immobilized antibodies, said column and said competitive binding component coupled to allow a continuous flow of eluent to pass from said column into said binding component; and (c) a detector effective to quantitatively determine the amount of fluorescently labeled antigen displaced from said competitive binding component by the passage of unlabeled sample antigen through said binding component, said detector being coupled to said competitive binding component to allow a continuous flow of said eluent to pass from said competitive binding component to said detector.
Claim 12
Dependent Claim 41 words
The device claim 9, further including (d) a recorder coupled with said detector for recording the amount of fluorescently labeled antigen displaced from said competitive binding component and detected by said detector; and (e) an eluent collector coupled with said detector.

References Cited (Backward Citations)

US4036946A Cited
US4251360A Cited
US4108603A Cited
US4264327A Cited
US4277560A Cited
US4456689A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-01-22 1993-07-24 1994-01-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-01-22 1997-07-24 1998-01-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-01-22 2001-07-24 2002-01-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag